The Pharmacological Aspects of Adalimumab Biosimilars
A clinical pharmacist reviews the various pharmacological aspects of the available adalimumab biosimilars.
Stay updated with breaking news from Peter Lio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A clinical pharmacist reviews the various pharmacological aspects of the available adalimumab biosimilars.
Clinicians and a pharmacist provide an overview of the emerging adalimumab biosimilars in the recent years.
Drs Lio, Botsoglou, and Axelrad discuss the need for biosimilars in inflammatory diseases, and clinical pharmacist Dr Humphreys reviews the regulatory requirements for biosimilars to receive FDA approval.
Scientists say climate change issues such as global warming can exacerbate the symptoms of atopic dermatitis, a skin condition also known as eczema
Lisa Swanson, MD, PhD, highlights dermatology biologics coordinators as a resource for getting better access to JAK inhibitors.